Advanced Search

2025 Vol. 7, No. 30

Commentary
World Hepatitis Day 2025: Progress and Challenges in the Global Elimination of Viral Hepatitis
Minghui Li, Weihua Cao, Yao Xie
2025, 7(30): 987-990. doi: 10.46234/ccdcw2025.167
Abstract(3607) HTML (51) PDF 267KB(4)
Abstract:

The year 2025 marks the 15th anniversary of World Hepatitis Day, a milestone that has witnessed remarkable progress in global viral hepatitis prevention and treatment. This article systematically examines the establishment and evolution of World Hepatitis Day, emphasizing the latest achievements in hepatitis control through 2025. Current data demonstrate that global hepatitis B vaccine coverage has surpassed the 90% target, while a cumulative 12,748,000 hepatitis C patients received direct-acting antivirals (DAAs) treatment from 2014 to 2023. Despite these advances, persistent challenges, including suboptimal diagnosis rates and pronounced regional disparities continue to impede progress toward the 2030 elimination objectives. Drawing from the most recent epidemiological data, this article presents targeted recommendations to accelerate global elimination efforts.

Preplanned Studies
Evaluations of Community-based Healthcare Management for Patients with Chronic Viral Hepatitis — Shanghai Municipality, China, 2012–2023
Hong Ren, Di Xu, Lingxiao Qu, Xin Shen, Kaiyun Chen, Qichao Pan, Jiayu Hu, Yang Shi, Jian Li, Xin Chen
2025, 7(30): 991-996. doi: 10.46234/ccdcw2025.137
Abstract(1510) HTML (35) PDF 397KB(4)
Abstract:
What is already known about this topic?

Current strategies for chronic viral hepatitis prevention and control include immunization, prevention of mother-to-child transmission, expanded testing, antiviral therapy, and national drug price negotiations. To advance high-quality, integrated prevention and treatment services, a decentralized service delivery approach may be beneficial.

What is added by this report?

The chronic viral hepatitis community-based healthcare management program in Shanghai delivered comprehensive service packages across 4 categories encompassing 10 distinct interventions, including epidemiological investigation, health education, free testing, community dispensing services, and immunization to family caregivers. The enrolled patients increased substantially from baseline, and antiviral treatment utilization rates reached 64.5% and 58.2% in 2019 and 2023 from 24.5% in 2012. Concurrently, abnormality rates for hepatitis B virus deoxyribonucleic acid (HBV DNA), alanine aminotransferase (ALT), total bilirubin (TBIL), and hepatic fibrosis indices decreased significantly. The 2023 aMAP score demonstrated a significant reduction in hepatocellular carcinoma risk among patients under management. Additionally, community dispensing services were accessed by 14.1% (2019) and 18.2% (2023) of enrolled patients.

What are the implications for public health practice?

The community-based healthcare management program could effectively decentralize hepatitis-related testing and treatment services, and create a favorable environment for the viral hepatitis elimination efforts.

Partner Tracing Survey and Phylogenetic Analysis Among Newly Diagnosed HIV-Positive MSM — Shenzhen City, Guangdong Province, China, 2019–2022
Hu Tang, Lan Wei, Zijie Yang, Yue Zhu, Yan Zhang, Chenli Zheng, Xiaohong Yuan, Jiachun Chen, Jin Zhao
2025, 7(30): 997-1003. doi: 10.46234/ccdcw2025.168
Abstract(1391) HTML (36) PDF 354KB(7)
Abstract:
What is already known about this topic?

Partner tracing (PT) represents an established public health strategy for identifying undiagnosed individuals with human immunodeficiency virus (HIV) infection and contributes to controlling sustained HIV transmission.

What is added by this report?

Partner tracing among newly diagnosed HIV-infected men who have sex with men (MSM) demonstrates effectiveness in identifying undiagnosed infected individuals, with regular sexual partners showing higher likelihood of HIV-positive detection. However, phylogenetic analysis revealed that only a small proportion of epidemiologically linked pairs exhibited genetic linkage.

What are the implications for public health practice?

Sustained implementation and broader application of partner tracing may serve a critical role in HIV epidemic control by facilitating early identification of undiagnosed infections and interrupting potential transmission chains. Integrating partner tracing with phylogenetic analysis enhances the capacity to distinguish actual transmission chains from coincidental behavioral associations, thereby improving transmission linkage identification accuracy and informing more targeted intervention strategies.

Outbreak Reports
The First Imported Case of Zika Virus Infection — Shandong Province, China, 2025
Shu Zhang, Julong Wu, Dong Wang, Jiandong Song, Yan Li, Chunhong Yin, Chengxi Sun, Shujun Ding, Ti Liu, Zengqiang Kou
2025, 7(30): 1004-1008. doi: 10.46234/ccdcw2025.169
Abstract(1993) HTML (110) PDF 240KB(6)
Abstract:
What is already known about this topic?

Zika virus (ZIKV) is transmitted primarily through mosquito vectors, including Aedes albopictus and Aedes aegypti, both of which are distributed across multiple provinces in China. Approximately 80% of ZIKV infections remain asymptomatic, while symptomatic cases typically manifest as mild, self-limiting illnesses lacking pathognomonic features. Common clinical presentations include maculopapular rash, low-grade fever, conjunctivitis, arthralgia, and myalgia.

What is added by this report?

The clinical manifestations of ZIKV infection are nonspecific and may closely mimic other febrile illnesses, complicating differential diagnosis. This study documents the first laboratory-confirmed ZIKV infection case in Shandong Province. The patient exhibited fever accompanied by extensive subcutaneous petechiae, predominantly distributed across the chest and upper extremities.

What are the implications for public health practice?

This investigation provides a comprehensive epidemiological analysis and phylogenetic characterization of a ZIKV infection case imported from Thailand. In accordance with China’s Border Health and Quarantine Law, international port cities must strengthen surveillance and diagnostic testing for imported infectious diseases. For cases presenting with unclear diagnoses, healthcare providers should prioritize obtaining detailed 30-day travel histories to evaluate potential exposure risks of imported infectious diseases.

Notifiable Infectious Diseases Reports